Drugs · acquisition-cost intelligence
Haldol Decanoate
Haloperidol Decanoate· ingredient haloperidol· HALOPERIDOL DECANOATE 100 mg/mL; HALOPERIDOL DECANOATE 50 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$13.25
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other haloperidol products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| haloperidol | $0.12000 | −$13.13 |
| haloperidol | $0.15824 | −$13.09 |
| haloperidol | $0.16451 | −$13.09 |
| haloperidol | $0.18012 | −$13.07 |
| Haloperidol | $0.47029 | −$12.78 |
| Haloperidol | $0.77873 | −$12.47 |
| Haloperidol | $0.77873 | −$12.47 |
| Haloperidol decanoate | $13.25 | +$0.00000 |
Medicare Part D coverage · CY2026
On 323 plan formularies · typical tier 4
Prior auth 14% · Step therapy 0% · Quantity limit 0% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.